The relationships between the pharmaceutical and healthcare industries have always relied on ethical conduct to ensure the integrity and safety of scientific research. In recent years, however, concerns have arisen that the wide-ranging financial ties between these industries may be influencing the judgment of professionals regarding the main goals of medicine. Thus, the scrutiny of these industries by the government, the public, and the media is at an all-time high.
Why are financial conflicts of interest seen as posing a particular threat to the integrity of scientific research? How have professional associations of editors, medical writers, and scientific journals responded to concerns about conflicts of interest? What is the role of the government in addressing these concerns? What are the roles of professional medical writers and medical communications companies?
This white paper answers these questions, and more, for those who are new to the pharmaceutical industry and to supporting companies and organizations, those who manage new hires in pharma and in supporting companies and organizations, and those in pharma interested in hiring a medical communications company.
To read the white paper please click below
Keeping Medical Communication Afloat in a Sea of Interests